I was recently talking to Paulo Machado about what digital health was happening at the CES conference in Las Vegas (see my full schedule of Health Care IT Conferences and Events). Over the 10 years I’ve been going to the event, digital health has really grown at CES. Plus, it has its own subsection called the Digital Health Summit. I’ll actually be speaking at CES as part of a panel on genomics called “Look Who’s Talking: Newborn Genomic Data Enables Precision Medicine” which is happening January 7th, 2:15 PM – 2:40 PM if you’d like to attend.
As I was talking about digital health at CES, I learned that Paulo is now CEO of an evidence based digital therapy company. I’ve long loved the concept of evidence based digital therapies and I was glad to see someone like Paulo working on them. For those not familiar with digital therapies, here’s a look at the top 3 companies in the space:
Claritas MindsSciences designs evidence based digital therapies that empower people to manage their cravings and addictions. Dr. Judson Brewer founded the company when he was leading Yale’s Therapeutic Neuroscience Clinic. Our digital solutions deliver evidence-based mindfulness training in a personalized, cost effective & scalable fashion. Our first product, Craving to Quit is a 21 session smoking cessation program based on an NIH funded randomized controlled clinical trials which showed that our approach was twice as effective as gold standard treatment at the end of therapy and was >5x as effective at week 17 with a quit rate of 31%. Healthy Eating and Opioid/Drug addiction solutions will be launched in 2016.
Omada works with employer and health plan customers to provide scalable, effective, and evidence-based behavioral interventions for those at risk for heart disease, diabetes, and other chronic conditions. Combining proven behavioral science and the clinically-meaningful results for a tipping point population – those most at-risk for developing obesity-related chronic diseases. Omada operates on a pay-for-outcomes pricing model that eliminates risk for enterprise customers, and is helping drive the company’s growth in the marketplace.
WellDoc is a digital health technology company that develops mobile solutions to drive behavioral and clinical change in chronic disease. WellDoc’s goal is to improve patient self-management and help physicians overcome gaps in the delivery system to improve clinical outcomes and decrease cost. WellDoc has commercialized the first mobile prescription therapy, BlueStar®, for adults with type 2 diabetes. Mobile prescription therapy fills the support gap between patients and providers during the 8700 hours that individuals are living their lives outside the healthcare system. WellDoc has a proven track record of contributing published, peer-reviewed clinical evidence since 2008 and in June 2015 presented real-world patient engagement and clinical outcomes at the American Diabetes Association’s (ADA) 75th Scientific Session. BlueStar is recognized by the ADA on its website as the first and only in the new class of diabetes treatment known as Mobile Prescription Therapy.
I’m sure there are other companies that are working on digital therapies. Please share them in the comments. It’s time we spend a lot more time learning about these companies since companies like these are going to transform health care as we know it.